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Abstract
The elevation of the cytosolic and nuclear Ca2 concentration is a fundamental signal transduction mechanism in almost
all eukaryotic cells. Interestingly, three Ca2-mobilising second messengers, D-myo-inositol 1,4,5-trisphosphate (InsP3), cyclic
adenosine diphosphoribose (cADPR), and nicotinic acid adenine dinucleotide phosphate (NAADP) were identified in a
phylogenetically wide range of different organisms. Moreover, in an as yet very limited number of cell types, sea urchin eggs,
mouse pancreatic acinar cells, and human Jurkat T-lymphocytes, all three Ca2-mobilising ligands have been shown to be
involved in the generation of Ca2 signals. This situation raises the question why during evolution all three messengers have
been conserved in the same cell type. From a theoretical point of view the following points may be considered: (i) redundant
mechanisms ensuring intact Ca2 signalling even if one system does not work, (ii) the need for subcellularly localised Ca2
elevations to obtain a certain physiological response of the cell, and (iii) tight control of a physiological response of the cell by
a temporal sequence of Ca2 signalling events. These theoretical considerations are compared to the current knowledge
regarding the three messengers in sea urchin eggs, mouse pancreatic acinar cells, and human Jurkat T lymphocytes. ß 2000
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1. Introduction
One of the fundamental intracellular signalling
mechanisms that can be found in almost all eukary-
otic organisms is the elevation of the intracellular
Ca2 concentration ([Ca2]i). In the normal, non-ac-
tivated state of a cell ATP-driven Ca2 pumps de-
crease the concentration of free Ca2 ions in the
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cytosol and the nucleus to values of 100 nM or be-
low. Thereby, these Ca2-ATPases keep up high
Ca2-gradients between the cytosol and both the
extracellular space and the intracellular Ca2 stores.
Activation of the cell by an external input signal
often results in an elevation of [Ca2]i by opening
of Ca2 channels located either in membranes of
intracellular Ca2 stores or in the plasma membrane.
In this review we shall focus on the role of Ca2
release from intracellular Ca2 stores.
Currently, at least three Ca2-mobilising intracel-
lular ligands are known. D-myo-Inositol 1,4,5-tris-
phosphate has been discovered by Schulz and
Berridge [1], while both cyclic adenosine diphosphor-
ibose (cADPR) and nicotinic acid adenine dinucleo-
tide phosphate (NAADP) have been described for
the ¢rst time by Lee and co-workers [2^4]. Both
InsP3 and cADPR have been accorded full status
as second messengers in di¡erent cell systems, mainly
based on the fact that, in addition to their intracel-
lular Ca2-release activity, an increase in their intra-
cellular concentration upon stimulation of receptors
in the plasma membrane was observed. A similar
result has not yet been published for NAADP,
although enzymatic formation of NAADP was
demonstrated [5,6].
In addition to the three compounds mentioned
above, the lipids lysophosphatidic acid and phospha-
tidic acid released Ca2 from intracellular stores in
permeabilised cells (Jurkat T cells [7,8]). The e¡ect of
these lipids was independent of InsP3 or cADPR
[7,8]. However, lysophosphatidic acid also exerted
Ca2-releasing e¡ects on intact cells [8,9], raising
the question whether it primarily acts on plasma
membrane-bound receptors or on intracellular tar-
gets or on both. Because of these uncertainties, we
will not include the Ca2-mobilising lipids in this
review.
2. Why did evolution conserve three (or more)
Ca2+-mobilising intracellular ligands within the
same cell type? Theoretical considerations
Since many aspects of the physiological role of the
three Ca2-mobilising messengers InsP3, cADPR,
and NAADP in di¡erent cell systems are not yet
clari¢ed, it is very di⁄cult to say why at least the
InsP3- and the cADPR-system have been conserved
between unicellular protozoa, e.g., Euglena gracilis
[10] and many mammalian cells, including cells of
human origin (reviewed in [11,12]). For NAADP
a role in lower, unicellular eukaryotes has not yet
been described, but the fact that the NAADP sys-
tem appears to be highly conserved between sea ur-
chin eggs [5], ascidian eggs [13], pancreatic acinar
cells [6] and human Jurkat T cells [90] indicates
that it may be similarly widespread as has been dem-
onstrated for the InsP3- and cADPR-system.
The reasons for such long conservation of these
di¡erent Ca2-mobilising systems during evolution
are di⁄cult to assess, but it may be worth consider-
ing the following points.
In a simpli¢ed view, one may regard the di¡erent
Ca2-mobilising second-messenger systems to end up
in the very same ¢nal result, a global Ca2 response
that can be seen throughout the entire cell, although
with cell type speci¢c di¡erences. Assuming that this
¢nal result, a global Ca2 response, is required for a
particular physiological response, then it may be of
minor interest for the cell which Ca2 releasing sys-
tem is used. On the other hand, if the particular
physiological response cannot take place without a
global Ca2 response, evolution may have conserved
two (or more) signalling systems (Fig. 1A, (a^c))
which are activated in parallel, and therefore may
serve as redundant mechanisms to ensure that the
cell can respond to a given extracellular signal.
Blockade of one particular signalling system (Fig.
1A, (c)) would neither inhibit the development of
the Ca2 signal nor the physiological response.
Another reason for the use of more than one
Ca2-mobilising second-messenger system would be
to elevate [Ca2]i in di¡erent regions of the cell, e.g.,
to activate a physiological response which can be
carried out only in a localised area of the cell. In
this case one would expect a discrete subcellular lo-
calisation of second-messenger forming and/or me-
tabolising enzymes, and/or of the intracellular Ca2
stores sensitive to the di¡erent messengers, and either
a localised Ca2 signal or a regional or global Ca2
wave (Fig. 1B). Such a scenario would also be help-
ful for cells which respond to di¡erent input signals
by di¡erent, ¢ne-tuned Ca2 elevations. The latter
then may elicit di¡erent physiological responses.
The temporal aspect of Ca2 signalling may re-
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quire as well the use of more than one second mes-
senger. Two or more endogenous Ca2-mobilising
compounds formed (and degraded) in sequence
may o¡er more control points for the cell, e.g., in
case that a physiological response is initiated, but
needs to be controlled tightly before a ¢nal decision
to launch a physiological response or not is made
(Fig. 1C).
Finally, localised Ca2 responses of di¡erent am-
plitude and length may be required for the ¢ne-tun-
ing of physiological responses. Thus, from the evolu-
tionary point of view di¡erent Ca2-mobilising
second-messenger systems should vary in their signal
amplitudes, as well as in temporal and spatial pat-
tern.
3. Ca2+ signalling mediated by InsP3, cADPR and
NAADP+
There is increasing evidence that internal Ca2
stores can be mobilised by InsP3, cADPR or
NAADP via totally distinct mechanisms. Each of
these three compounds and the Ca2 signalling path-
ways in which they participate present di¡erent im-
portant characteristics, which are brie£y described in
this section. A summary of some of the properties of
these Ca2-mobilising compounds and their recep-
tors is shown in Table 1.
InsP3 is a well established second messenger in-
volved in Ca2 signalling in many types of cells.
Under resting conditions, intracellular concentra-
tions of InsP3 are very low, but the levels of this
compound increase rapidly, following stimulation
of cell-surface receptors and subsequent activation
of the enzyme phospholipase C (L or Q, depending
on the type of cell ; PLC) by G proteins or by recep-
tor or non-receptor tyrosine kinases [14^18]. Acti-
vated PLC promotes the hydrolysis of the membrane
phospholipid phospatidylinositol 4,5-bisphosphate
(PtdInsP2) with production of the two second mes-
sengers InsP3 and 1,2-diacylglycerol. Subsequent in-
teraction of InsP3 with its speci¢c receptor ^ the ino-
sitol 1,4,5-trisphosphate receptor (InsP3R)/channel,
identi¢ed in three isoforms ^ induces the release of
Ca2 from intracellular pools located in the endo-
plasmic reticulum ([14,19], reviewed in [20]).
Studies performed in di¡erent cell types show that
InsP3Rs are activated by InsP3 in the nanomolar to
low micromolar concentration range [15,21^23] (Ta-
ble 1). In addition to InsP3, other physiological mod-
ulators of InsP3R-activity have been described,
namely Ca2 and ATP, which can stimulate the re-
ceptor, and Mg2 which has an inhibitory e¡ect on
InsP3R/channel activity ([24,25], reviewed in [20]).
The e¡ects of Ca2 on InsP3R-activity, however, de-
pend on the subtype of InsP3R expressed, since the
open probability of type 1 InsP3R displays a biphasic
dependence on cytoplasmic Ca2 and on calmodulin
(CaM), whereas the open probability of type 3 InsP3R
increases monotonically with increasing Ca2 con-
centration [26^28].
Moreover, the activity of the InsP3R can also be
modulated by phosphorylation by cAMP-dependent
protein kinase (PKA) as well as by protein kinase C
Fig. 1. Potential roles for three Ca2-mobilising messengers
within the same cell type. The three Ca2-mobilising messenger
systems (a), (b), and (c) either act in a redundant fashion (A),
or elevate Ca2 in one or more subcellular regions of the cell
(B), or act in a temporal sequence giving the cell several check-
points (CP) to decide whether the physiological response is ¢-
nally launched or not (C).
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Table 1
Characteristic properties of systems for Ca2 release from intracellular stores
Second messenger InsP3 Ref. cADPR Ref. NAADP Ref.
Synthesising
enzyme
PLC-L,Q [14] ADP-ribosyl
cyclase; CD38 (?)
[3,32] ADP-ribosyl cyclase/
CD38 (?)
[5]
[15] [46] NAD(P)-glyco-
hydrolase (?)
[11]
[16] [47]
[17]
Mechanism of
activation of
biosynthesis
G-protein [16] PKG [41,42] ND
Tyr-kinases [17] G-protein [43,44]
[18] Tyr-kinases [45]
Substrate PtdInsP2 [14] L-NAD [3] L-NADP (?) [11]
Enzymatic
degradation
InsP3-3-kinase [40] cADPR-hydrolase/
NADase
[12,32] Alkaline
phosphatase (?)
[11]
InsP3-5-phosphatase [39] Pyrophosphatase (?) [32]
Di¡usion
coe⁄cient
(Wm2/s)
283 [33] ND ND
Intracellular
receptor/channel
InsP3R (1,2,3) [20] RyR2 [50,51] ND
[24] RyR3
E¡ective
concentration
EC50 = 5 nM^10 WM [14] EC50 = 3.8 nM^
10 WM
[11] Low nanomolar
range
[11]
[21] [12]
[22] EC50 = 10^50 nM [68]
[23]
Physiological
modulators:
activators InsP3, Ca2 [20] cADPR; Ca2 [52^54] NAADP (nanomolar
concentration)
[5]
[27] CaM [57] [32]
ATP [25] Pi [58] [68]
PKC [20] Palmitoyl-CoA [60]
PKA [20] PKA [55,61]
CaM-kinase II [20] PKG [55,61]
Tyr-kinase [29] CaM-kinase [55,61]
inhibitors Mg2 [24] Mg2 [56] NAADP (high
concentration, WM)
[32]
Ca2 (high concentration,
type 1 InsP3R)
[26] Spermine and other
polyamines
[59] [72]
[28] PKC [62]
Non-physiological
modulators:
activators Adenophostins [32] Ryanodine [11] ND
inhibitors Ca¡eine [11]
Heparin [30] Ruthenium red,
procaine
[11] L-type Ca2-channel
antagonists
[73]
Xestospongin C [31] [11]
8-NH2-cADPR [12] and
[63,64]
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(PKC) and Ca2-calmodulin-dependent protein ki-
nase II (CaM kinase-II) (reviewed in [20]). Other
studies also demonstrated regulation of the InsP3R
by tyrosine phosphorylation [29].
Apart from these physiological modulatory e¡ects,
other non-physiological compounds have been
shown to a¡ect the activity of InsP3R/Ca2 channels
and are very useful as pharmacological tools for
studies on InsP3R-mediated Ca2 signalling. Among
such compounds, heparin and xestospongin C are
used as potent speci¢c antagonists of the InsP3R
and InsP3-mediated Ca2 release [30,31], whereas ad-
enophostins are used as activators of this system (re-
viewed in [32]).
Studies of the conduction properties of the InsP3-
gated Ca2 channel showed that, under physiological
conditions, the Ca2 current through the InsP3R is
0.5 pA, which is about four times less than the Ca2
current through the ryanodine receptor (RyR) [24].
The di¡usion coe⁄cient of InsP3 as measured in
cytosolic extracts from Xenopus laevis oocytes [33] is
283 Wm2/s, which corresponds to an e¡ective range of
messenger action of about 24 Wm. When compared
with corresponding values obtained for Ca2 (13^65
Wm2/s and 0.1^5 Wm, depending on the free Ca2
concentration), these parameters make InsP3 a
good candidate for the mobile messenger in Ca2
signalling in most cells.
Release of Ca2 from InsP3-sensitive intracellular
stores can give rise to elementary, highly localised
and short-duration events of Ca2 signalling called
pu¡s, which individually contribute a quantal
amount of Ca2, as described in Xenopus oocytes
[34], HeLa cells [35], smooth muscle [36] or pancre-
atic acinar cells [37]. The spatio-temporal properties
of Ca2 pu¡s arising from InsP3R have been studied
and are characterised by a duration of about 500 ms,
reaching ranges of 4^6 Wm (diameter of Ca2 signal)
and maximal amplitudes of elevation of [Ca2]i of
140 nM [38]. Global Ca2 signals result from the
coordination and summation of such elementary
Ca2 release units to produce regenerative waves of
Ca2 that spread throughout the cells, whereas local-
isation of these Ca2 release units to a particular
region of the cell can give rise to spatially-restricted
Ca2 signals.
Degradation of InsP3 is carried out by the enzyme
Ins(1,4,5,)P3 3-kinase, which is activated by Ca2/cal-
modulin, and/or by Ins(1,4,5,)P3 5-phosphatase
[39,40].
cADPR is a cyclic derivative of L-nicotinamide
adenine dinucleotide (NAD) which is synthesised
by ADP-ribosyl cyclase ([3], reviewed in [11,12,32]).
ADP-ribosyl cyclases are found both in membrane-
bound and soluble forms and the latter can be acti-
vated by a cGMP-dependent protein kinase, as de-
scribed in sea urchin eggs and PC12 cells [41,42] or
by G-protein coupled [43,44] or tyrosine-kinase
coupled receptors [45]. The membrane-bound ADP-
ribosyl cyclases usually have a prominent NAD gly-
cohydrolase (NADase) activity and, in a side reac-
tion, catalyse the synthesis of cADPR [46]. The sur-
face antigen CD38, mainly expressed on activated T
and B lymphocytes, natural killer cells and erythro-
cytes and in minor levels in other major organs, also
shows NADase activity and a minor ADP-ribosyl
Table 1 (continued)
Second messenger InsP3 Ref. cADPR Ref. NAADP Ref.
8-OCH3-cADPR
8-Bromo-cADPR
7-Deaza-8-bromo-
cADPR
Channel conduction
(pA)
0.5 [24] 2.0 [24] ND
Elementary Ca2
signals
Pu¡s [38] Sparks [38] ND
duration (ms) V500 6 200 ND
range (Wm) 4^6 3 ND
amplitude (nM) 140 170 ND
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cyclase activity [47]. However, the exact role of CD38
in the synthesis of intracellular cADPR is still con-
troversial and may di¡er between cellular systems.
Receptor-mediated increases in ADP-ribosyl cyclase
activity and concomitant formation of cADPR have
been reported in a number of cellular systems
[43,45,48].
cADPR is enzymatically degraded by NADases
(reviewed in [11,12,32]). Speci¢c cADPR hydrolases
have not yet been isolated.
The Ca2-releasing e¡ects of cADPR are thought
to be mediated through its interaction, either direct
or via accessory proteins, with RyR. RyR are known
for their role in the mechanism of Ca2-induced
Ca2 release (CICR) [49]. Three isoforms of RyR
have been identi¢ed and speci¢c stimulatory e¡ects
of cADPR on RyR subtypes 2 and 3 have been de-
scribed [50,51]. Several pharmacological studies indi-
cate that cADPR is a physiological modulator of
CICR [52^54]. In addition to cADPR, the activity
of the RyR/Ca2 channel is also modulated by other
physiological ligands, namely Ca2, CaM, inorganic
phosphate (Pi), palmitoyl-CoA, which have stimula-
tory e¡ects, and Mg2 (at high concentration) and
various polyamines, which are negative modulators
[11,32,55^60]. It should be mentioned that, in con-
trast to the InsP3-gated channel (type 1), which
shows both positive and negative feedback regulation
by Ca2, the RyR behaves as a Ca2-activated chan-
nel in the physiological range of Ca2 concentra-
tions.
There is also signi¢cant evidence that the activity
of the RyR can be modulated by phosphorylation by
di¡erent protein kinases, including PKA, PKG, PKC
and CaM-kinase. However, the e¡ects of receptor
phosphorylation on Ca2 release may be di¡erent,
depending on the type of cell or tissue (reviewed in
[55,61,62]).
Several compounds are presently used as pharma-
cological tools for studying cADPR-mediated Ca2-
release e¡ects. Among these, ryanodine and ca¡eine
have been shown to act as selective activators of
RyR, whereas ruthenium red, procaine and various
synthetic derivatives of cADPR, namely 8-NH2-,
8-methoxy, 8-bromo- and 7-deaza-8-bromo-cADPR,
are used as selective inhibitors of this receptor
([32,45,63]; for complete listing see [12,64]).
Self-desensitisation is another characteristic of the
cADPR-mediated Ca2-mobilisation system. In most
cellular systems studied so far cADPR exerts Ca2
release from intracellular stores in the nanomolar
and low micromolar range (EC50 ranging between
3.8 nM and 10 WM, using permeabilised cells and
cell homogenates) (reviewed in [11]) (Table 1).
The ionic conduction properties of the RyR are, in
general, similar to those reported for the InsP3R,
except for the di¡erence that ionic currents through
the RyR are approximately four times higher (2 pA),
as compared to the InsP3R [24].
In analogy to the InsP3R, RyR are also involved
in the generation of elementary Ca2 release events
called sparks, as observed, for example, in cardiac
muscle cells [38,65,66]. The spatio-temporal proper-
ties of Ca2 sparks arising from RyR are, however,
slightly di¡erent from the ones described for Ca2
pu¡s arising from activation of InsP3R. Ca2 sparks
show a duration of less than 200 ms and spatial
ranges of about 3 Wm and have maximal amplitudes
of elevation of [Ca2]i of 170 nM [38].
In contrast to the InsP3- and cADPR-signalling
pathways, many aspects of NAADP-mediated
Ca2 signalling are still unknown. In spite of the
experimental evidence for an NAADP-synthesising
activity in some types of cells and tissue homogenates
[6,67], and the observations that ADP-ribosyl cyclase
or CD38 can catalyse the synthesis of NAADP
from L-NADP and nicotinic acid at acidic pH [5],
the identity of the enzyme involved in intracellular
synthesis of NAADP is still not known. Also the
intracellular receptor for NAADP has so far not
been identi¢ed. However, results from di¡erent types
of cells show that, in general, NAADP induces
Ca2 release at much lower concentrations (low
nanomolar range), as compared to InsP3 and
cADPR ([68], reviewed in [11,12]). The NAADP-
induced Ca2-release mechanism is clearly distinct
from those controlled by InsP3 and cADPR, since
(i) it is not blocked by known antagonists of InsP3
and cADPR [4] and (ii) there is no cross-desensitisa-
tion between NAADP- and InsP3/cADPR-induced
Ca2-release mechanisms [4,69].
Moreover, NAADP-induced Ca2 release is ki-
netically faster than the corresponding mechanisms
induced by either cADPR or InsP3 [4] and, in con-
trast to the latter, NAADP-triggered Ca2 release is
independent of the cytoplasmic Ca2 concentration
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and, therefore, does not behave as a CICR system
[70]. In addition, this mechanism is not a¡ected by
divalent cations such as Mg2 [70]. Another observa-
tion is that the NAADP-sensitive Ca2-pools seem
to be localised in an intracellular compartment
clearly separated from those Ca2-pools sensitive to
InsP3 and cADPR, i.e., not contained within the ER
[71]. Further important characteristics of the
NAADP-mediated Ca2 release are its self-desensi-
tisation and self-inactivation. Sub-threshold concen-
trations of NAADP can completely and irreversibly
block any further Ca2 release by this compound in
sea urchin eggs, probably due to a complete inacti-
vation of receptors [71,72]. Due to this unique prop-
erty, it is unlikely that NAADP itself is responsible
for long term Ca2 oscillations. In addition, higher
(WM) concentrations of NAADP desensitise the
Ca2-release system without mediating any Ca2 re-
lease.
A pharmacological study in sea urchin eggs
showed that Ca2 release mediated by NAADP
can be speci¢cally inhibited by some L-type Ca2
channel blockers [73].
Although the precise mechanism of degradation of
NAADP in cells is also not known, potential path-
ways include the enzymes alkaline phosphatase and
nucleotide pyrophosphatase [11,32].
4. InsP3-, cADPR- and NAADP+-mediated Ca2+
signalling: multiple pathways with distinct functions
within one cell?
Evidence for an active role of all three Ca2-re-
lease pathways has only been obtained in a very
limited number of cell systems. Examples of these
are sea urchin eggs, pancreatic acinar cells and T
lymphocytes. In this section, some considerations
about the possible functions of three di¡erent
Ca2-signalling pathways in these cell types will be
presented.
4.1. Redundant Ca2+-signalling pathways ensure
fertilisation of sea urchin eggs
Analysis of fertilisation of sea urchin eggs shows
that a transient rise in [Ca2]i occurs immediately
after sperm^egg fusion and propagates across the
cytoplasm [11]. This Ca2 wave, which is required
for metabolic activation of the quiescent egg, is due
to Ca2 release from intracellular stores. When mi-
croinjected in sea urchin eggs, InsP3 and cADPR are
Fig. 2. Roles for the three Ca2-mobilising messengers InsP3,
cADPR, and NAADP in sea urchin eggs, pancreatic acinar
cells, and Jurkat T lymphocytes. (A) In sea urchin eggs either
the InsP3 or the cADPR pathway is su⁄cient for fertilisation.
Blockade of one of these pathways ^ for this ¢gure the cADPR
pathway was chosen randomly ^ does not inhibit fertilisation.
The NAADP/Ca2 release system is active in sea urchin eggs;
however, its role in the process of fertilisation is not yet clari-
¢ed. (B) In pancreatic acinar cells InsP3 is generated upon
cholecystokinin and acetylcholine stimulation. InsP3 acts at the
luminal pole of the cell. The local rise in Ca2 at this site then
allows secretory granules to fuse to the plasma membrane.
NAADP and cADPR may be involved in the response to
cholecystokinin, but not to acetylcholine, according to the mod-
el of Petersen and Cancela [83,84]. A Ca2 wave then swaps
from the luminal to the basolateral pole of the cell which is
carried by cADPR-mediated Ca2 release [77]. The site of
NAADP-mediated Ca2 release has not yet been localised.
(C) In T cells NAADP, InsP3, and cADPR may be formed in
a temporal sequence resulting in long-lasting Ca2 signals that
are controlled stepwise by the di¡erent messengers. This may
allow the cell to use the generation and/or metabolism of these
messengers as checkpoints to tightly control the physiological
response, e.g., proliferation of T cells.
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both able to trigger independently Ca2-mobilisation
during fertilisation [53,74]. Inhibition of either InsP3-
mediated or cADPR-mediated Ca2 release was in-
su⁄cient to prevent the cortical reaction and prop-
agation of Ca2 waves associated with fertilisation,
whereas inhibition of both signalling pathways pre-
vented these phenomena [53,74]. More recently, an
additional Ca2-release system triggered by
NAADP has been described in sea urchin egg
homogenates as well as in intact cells [4,69,75].
NAADP induces Ca2 release by a mechanism dis-
tinct from those triggered by InsP3 and cADPR, as
demonstrated by (i) a lack of inhibition by the InsP3
and cADPR antagonists heparin and 8-amino-
cADPR, and (ii) no cross-desensitisation between
NAADP- and InsP3/cADPR-induced Ca2-release
mechanisms. In addition, once fertilisation occurred,
no further e¡ects of microinjected NAADP on
Ca2 release were observed, suggesting that fertilised
eggs are desensitised to NAADP [75].
Taken together, these data demonstrate that InsP3-,
cADPR- as well as NAADP-dependent Ca2-re-
lease mechanisms may all be involved in fertilisation
in sea urchin eggs. Although the signi¢cance of the
complex control of Ca2 release during fertilisation
remains to be elucidated, the available experimental
data indicate that the cADPR- and the InsP3 path-
ways act in parallel and independently of each other.
Thereby, these independent pathways for Ca2-mo-
bilisation constitute redundant control mechanisms
to ensure the development of the Ca2 waves re-
quired for metabolic activation of fertilised eggs
(Fig. 2A).
4.2. Localised Ca2+ stores allow Ca2+ signalling in all
regions of pancreatic acinar cells
Pancreatic acinar cell are structurally and func-
tionally polarised having the secretory granules con-
centrated at the apical (luminal) pole. Fluid and en-
zyme secretion by acinar cells is mediated by agonist-
induced increases in [Ca2]i which start in a trigger
zone at the luminal cell pole and spread as a Ca2
wave to the basal cell side [76,77]. Electrophysiolog-
ical studies showed that agonist-induced Ca2 signals
in pancreatic acinar cells can be mimicked, at least in
part, by infusion of InsP3 [37] and selective injections
of InsP3 into di¡erent parts of the cell showed that
the Ca2 release mechanism has a much higher sen-
sitivity for this messenger in the secretory pole than
in the basal part of the cell [78]. In addition, type 3
InsP3R have been identi¢ed and localised in the lu-
minal pole of pancreatic acinar cells [79]. On the
other hand, propagation of agonist-induced Ca2
waves from the luminal to the basal pole could be
reduced by ryanodine and ca¡eine [80], known mod-
ulators of RyR, while microinjection of cADPR or
of a sub-threshold concentration of Ca2 into pan-
creatic acinar cells induced increases in Ca2 and
repetitive Ca2 spikes which originated in a region
distinct from the trigger zone [78,81]. cADPR-in-
duced Ca2 spikes as well as Ca2 signals elicited
by the peptide hormone cholecystokinin were inhib-
ited by ryanodine [81]. Furthermore, evidence has
also been obtained for expression of the type 2
RyR in pancreatic cells and for its polarised distri-
bution throughout the cell, mainly localised in the
basolateral region and, to a much lesser extent, in
the apical region [82].
Taken together, these ¢ndings suggest that ago-
nist-induced Ca2 signals in pancreatic acinar cells
start with formation of InsP3 in the basal pole and
its rapid di¡usion (di¡usion coe⁄cient; see Table 1)
to its receptor sites followed by Ca2 release in the
apical region. Subsequent propagation of Ca2
waves then proceeds via a CICR mechanism based
on activation of RyR and mediated by cADPR.
The di¡erential, polarised spatial distribution of in-
tracellular receptors/Ca2 channels in acinar cells,
i.e., with InsP3R localised exclusively in the apical
pole and RyR essentially in the basal pole, there-
fore accounts for and correlates with the pattern
and mechanism of Ca2 wave propagation in this
cellular system (Fig. 2B). The observation that
cADPR-induced Ca2 signals can be blocked by
the InsP3 antagonist heparin suggests, in addition,
a close link between the InsP3- and the cADPR-
mediated signalling mechanisms in pancreatic acinar
cells [81].
In spite of this, NAADP was recently shown to
induce also repetitive Ca2 spikes in pancreatic aci-
nar cells, at a concentration much lower than that
required for InsP3 and cADPR to induce similar ef-
fects (50 nM versus 10 WM) [6]. Interestingly, in con-
trast to observations in other cell systems, the
NAADP-mediated Ca2 signals in pancreatic aci-
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nar cells could be inhibited by the cADPR antagonist
8-NH2-cADPR and by the InsP3R antagonist hepa-
rin [6]. Self-desensitisation was also observed at high
concentrations of NAADP. Such desensitising con-
centrations of NAADP markedly inhibited chole-
cystokinin-induced Ca2 signalling [6]. These exper-
imental evidences, therefore, indicate also the
involvement of NAADP, in addition to InsP3 and
cADPR, in agonist-induced Ca2 signalling in pan-
creatic acinar cells. Based on these experimental
data, Petersen and Cancela recently proposed a mod-
el in which NAADP-induced Ca2 release functions
as a trigger, while the cADPR- and InsP3-mediated
Ca2 release systems would act as Ca2 ampli¢er and
Ca2 oscillator [83]. However, due to the lack of
information regarding the identity and intracellular
localisation of the NAADP receptor and the
NAADP-sensitive Ca2 pools, it is di⁄cult at
present to establish further correlations between the
spatial intracellular organisation of Ca2 channels
and the above model in which three di¡erent Ca2
release systems cooperate to regulate the complex
spatio-temporal patterns of Ca2 signals in pancre-
atic acinar cells.
Very recently, it has been reported that acetyl-
choline stimulation of Ca2 signalling in acinar cells,
in contrast to cholecystokinin, is neither inhibited
by desensitisation of the NAADP system nor by
inhibition of the cADPR system [84]. Cancela et al.
concluded that activation by cholecystokinin involves
the NAADP as the trigger and the cADPR and
InsP3 system as ampli¢er/oscillator, whereas in the
case of acetylcholine the InsP3 system serves both as
trigger and ampli¢er/oscillator [84]. Remarkably, us-
ing confocal Ca2 imaging there was no signi¢cant
di¡erence between acetylcholine or cholecystokinin
stimulation indicating that the e¡ects of both
NAADP and cADPR must be very low in am-
plitude or short in duration [84]. Interestingly,
the physiological responses of acinar cells to chole-
cystokinin and acetylcholine are not identical :
both agonists stimulate £uid and enzyme secre-
tion, but cholecystokinin in addition promotes pan-
creatic growth [84]. This may indicate the involve-
ment of both the NAADP and the cADPR
system re£ect the need for additional ¢ne tuning of
the Ca2 signal to achieve this growth promoting
e¡ect.
4.3. T-Cell activation can be controlled by
sequentially recruited Ca2+-signalling pathways
Stimulation of T lymphocytes via the T-cell recep-
tor (TCR)/CD3 complex results in activation of sev-
eral signal transduction pathways, including an ele-
vation of [Ca2]i which is essential for cell
proliferation and clonal expansion (reviewed in
[85]). The increase of [Ca2]i is due to release of
Ca2 from intracellular stores and subsequent Ca2
entry from the extracellular medium [85]. InsP3 and
cADPR are both involved in the process of Ca2
release in T lymphocytes [86^89] and, in addition, a
second-messenger role for these compounds has been
demonstrated by (i) increases in their intracellular
concentration upon stimulation of the TCR/CD3
complex, and (ii) the inhibitory e¡ect of the InsP3
antagonist xestospongin C and the cADPR antago-
nist 7-deaza-8-Br-cADPR on TCR/CD3-mediated
Ca2 signalling [45,89]. InsP3 acts primarily in the
initial phase of Ca2 signalling in T cells, whereas
cADPR is involved in both the initial and the sub-
sequent sustained phase. More recently, an addi-
tional, important role of NAADP in Ca2 sig-
nalling in Jurkat T cells has been described [90].
Microinjection of NAADP into intact T cells stimu-
lated Ca2 signalling in a speci¢c and dose-depen-
dent manner. In addition, both InsP3- and cADPR-
mediated Ca2 release depended upon a functional
NAADP/Ca2-release system. Moreover, self-inac-
tivation of the NAADP/Ca2 release completely in-
hibited Ca2 signalling mediated by activation of the
TCR/CD3 complex [90]. Based on these experimental
observations, a model is proposed in which each of
the three Ca2-mobilising messengers acts in a tem-
poral sequence to regulate Ca2 signalling in T cells.
In spite of the lack of information about changes
in NAADP concentration upon T-cell stimulation,
it is proposed that NAADP (either in basal nano-
molar concentrations or eventually in higher stimu-
lated levels) acts as the ¢rst messenger to provide a
trigger-Ca2 which subsequently activates the other
two Ca2-mobilising systems. The NAADP-in-
duced £ow of trigger Ca2 sequentially activates
the InsP3/Ca2-release system and, together with in-
creased levels of InsP3, which are formed rapidly and
transiently after cell stimulation, promotes further
increases in Ca2. This would subsequently lead to
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activation of RyR and the cADPR/Ca2-release sys-
tem so that, in concert with cADPR which is ele-
vated in the sustained phase of Ca2 signalling [45],
further major increases in Ca2 occur.
In summary, the model presented above consti-
tutes an example of how three di¡erent Ca2-mobi-
lising messengers, with their speci¢c and de¢ned
functions and characteristic signalling pathways,
may provide a temporal regulation of Ca2 signalling
in T cells. This sequential organisation may allow the
T cell to use each system as a sort of checkpoint;
commitment of T cells to activation may be tightly
controlled by each of these di¡erent checkpoints
(Fig. 2C). Although no information is presently
available on the kinetics of synthesis of NAADP
in T cells, this model is in accordance with the ki-
netics of InsP3 and cADPR formation, i.e., rapid and
marked elevation of InsP3 in the ¢rst minutes after
cell stimulation and slower increase in intracellular
levels of cADPR, which then remain elevated for a
longer period of time [45].
5. Conclusion
Three cellular models have been reviewed to ob-
tain an insight of understanding into why during
evolution the three Ca2-mobilising messengers In-
sP3, cADPR, and NAADP have been conserved
in the same cell types. The experimental data ob-
tained so far indicate cell type-speci¢c di¡erences re-
garding the individual role of each of the three Ca2
mobilisers. Although many experimental details have
been collected in the past, large gaps in our current
knowledge of the detailed intracellular processes do
not allow the development of more conclusive mod-
els. In spite of this, the ideas described in this article
hopefully will stimulate research in this fascinating
¢eld and thus may be used as working hypothesis
to be veri¢ed or falsi¢ed in the future.
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